Amneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s Treatment
Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...
Mallinckrodt, a pharmaceutical giant launched in St. Louis, to take over Endo in $6.7B deal
Mallinckrodt PLC, an Irish pharmaceutical company with a big footprint and long history in the St. Louis area, will buy U.S.
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)Lifecore ...
Medscape15h
Significant Improvement in Psoriasis Observed With Novel Oral Drug Icotrokinra, in Phase 3 Trial
Adults taking the novel once-daily oral pill for plaque psoriasis had significantly higher rates of clear or almost clear ...
BUCKSCO.Today on MSN20h
Malvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion Deal
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical ...
MyChesCo on MSN1d
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Proficio Capital Partners LLC Purchases New Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
Proficio Capital Partners LLC acquired a new position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) in the ...
Assetmark Inc. Buys 4,851 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Assetmark Inc. boosted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1,370.3% ...
Endo International plc (ENDPQ) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ETCompany ParticipantsLaure Park - Senior Vice President ...
POST Online Media3d
Mallinckrodt and Endo announce $6.7B merger
Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after ...
The Nashua Telegraph3d
Mallinckrodt to take over Endo in deal valued at $6.7 billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said ...
BioWorld4d
Endo the line: Mallinckrodt merger worth $6.7B
The pairing of Mallinckrodt plc and Endo Inc. is expected to create a pharma heavyweight that will generate $3.6 billion in 2025 revenue after the duo combines their generic pharmaceuticals businesses ...